• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Patient preferences for empiric TB treatment initiation.患者对经验性抗结核治疗起始的偏好。
Int J Tuberc Lung Dis. 2025 Jan 1;29(1):38-40. doi: 10.5588/ijtld.24.0267.
2
Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda.乌干达痰涂片阴性 HIV 感染成人结核病疑似患者经验性抗结核治疗的临床预测因素和准确性。
PLoS One. 2013 Sep 6;8(9):e74023. doi: 10.1371/journal.pone.0074023. eCollection 2013.
3
Empiric tuberculosis treatment in South African primary health care facilities - for whom, where, when and why: Implications for the development of tuberculosis diagnostic tests.南非初级卫生保健机构中的经验性结核病治疗——对象、地点、时间及原因：对结核病诊断检测发展的启示
PLoS One. 2018 Jan 24;13(1):e0191608. doi: 10.1371/journal.pone.0191608. eCollection 2018.
4
Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?床边即时尿液 LAM 检测在住院 HIV 感染者的临床决策中是否有价值？
PLoS One. 2013;8(2):e54875. doi: 10.1371/journal.pone.0054875. Epub 2013 Feb 4.
5
Empiric TB Treatment of Severely Ill Patients With HIV and Presumed Pulmonary TB Improves Survival.对患有艾滋病病毒且疑似肺结核的重症患者进行经验性结核病治疗可提高生存率。
J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):297-303. doi: 10.1097/QAI.0000000000000970.
6
Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study.乌干达针对痰涂片和Xpert MTB/Rif检测均为阴性且疑似患有肺结核的门诊HIV感染患者的临床诊断算法的结果：一项前瞻性研究。
Pan Afr Med J. 2016 Mar 31;23:154. doi: 10.11604/pamj.2016.23.154.7995. eCollection 2016.
7
Pathways to care and preferences for improving tuberculosis services among tuberculosis patients in Zambia: A discrete choice experiment.赞比亚结核病人的就诊途径和改善结核服务的偏好：离散选择实验。
PLoS One. 2021 Aug 31;16(8):e0252095. doi: 10.1371/journal.pone.0252095. eCollection 2021.
8
Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy.尿液脂阿拉伯甘露聚糖检测在经验性抗结核治疗试验中对晚期人类免疫缺陷病毒感染成人的应用。
Clin Infect Dis. 2021 Aug 16;73(4):e870-e877. doi: 10.1093/cid/ciab179.
9
Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings.在多个高负担地区，对于开始接受抗逆转录病毒治疗且患有晚期人类免疫缺陷病毒的成年人，异烟肼依从性在96周时可降低死亡率和新发结核病。
Open Forum Infect Dis. 2022 Jul 3;9(7):ofac325. doi: 10.1093/ofid/ofac325. eCollection 2022 Jul.
10
"Allergic bronchopulmonary aspergillosis misdiagnosed as smear negative pulmonary tuberculosis; a retrospective study from Pakistan".误诊为涂片阴性肺结核的变应性支气管肺曲霉病：一项来自巴基斯坦的回顾性研究
Ann Med Surg (Lond). 2021 Nov 11;72:103045. doi: 10.1016/j.amsu.2021.103045. eCollection 2021 Dec.

本文引用的文献

1
Treatment preferences among people at risk of developing tuberculosis: A discrete choice experiment.结核病高危人群的治疗偏好：一项离散选择实验。
PLOS Glob Public Health. 2024 Jul 19;4(7):e0002804. doi: 10.1371/journal.pgph.0002804. eCollection 2024.
2
Causes of pre-treatment loss to follow-up in patients with TB.结核病患者治疗前失访的原因。
Public Health Action. 2022 Dec 21;12(4):148-152. doi: 10.5588/pha.22.0051.
3
Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda.评估乌干达公共卫生机构中治疗前失访对结核相关死亡率的影响。
PLoS One. 2020 Nov 18;15(11):e0241611. doi: 10.1371/journal.pone.0241611. eCollection 2020.
4
A clinical score for identifying active tuberculosis while awaiting microbiological results: Development and validation of a multivariable prediction model in sub-Saharan Africa.一种在等待微生物学结果时识别活动性结核病的临床评分：撒哈拉以南非洲地区多变量预测模型的开发和验证。
PLoS Med. 2020 Nov 10;17(11):e1003420. doi: 10.1371/journal.pmed.1003420. eCollection 2020 Nov.
5
Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective.GeneXpert MTB/RIF® 在乌干达推广面临的挑战：从卫生系统角度看。
BMC Health Serv Res. 2020 Mar 4;20(1):162. doi: 10.1186/s12913-020-4997-x.
6
Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trial.算法指导的经验性抗结核治疗用于晚期 HIV 感染者（TB Fast Track）：一项开放标签、整群随机试验。
Lancet HIV. 2020 Jan;7(1):e27-e37. doi: 10.1016/S2352-3018(19)30266-8. Epub 2019 Nov 11.
7
Pre-treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon.喀麦隆两个地区的肺结核患者治疗前失访情况。
Int J Tuberc Lung Dis. 2018 Apr 1;22(4):378-384. doi: 10.5588/ijtld.17.0676.
8
Barriers and facilitators to the uptake of tuberculosis diagnostic and treatment services by hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review of qualitative literature.难以接触的人群在低、中结核病发病率国家中获得结核病诊断和治疗服务的障碍和促进因素：定性文献的系统评价。
Lancet Infect Dis. 2017 May;17(5):e128-e143. doi: 10.1016/S1473-3099(16)30531-X. Epub 2017 Mar 11.
9
Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation.微生物学确诊的结核病：与治疗前失访及开始治疗时间相关的因素
PLoS One. 2017 Jan 9;12(1):e0168659. doi: 10.1371/journal.pone.0168659. eCollection 2017.
10
Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?用于结核病的Xpert MTB/RIF检测的开发、推广及影响：我们学到了哪些经验教训，如何才能做得更好？
Eur Respir J. 2016 Aug;48(2):516-25. doi: 10.1183/13993003.00543-2016. Epub 2016 Jul 13.

Patient preferences for empiric TB treatment initiation.

作者信息

Sung J, Musoke M, Baik Y, Twinamasiko A, Lamunu M, Nabacwa V, Sanyu A, Kityamuwesi A, Katamba A, Dowdy D W

机构信息

Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD, USA;, Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.

Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.

出版信息

Int J Tuberc Lung Dis. 2025 Jan 1;29(1):38-40. doi: 10.5588/ijtld.24.0267.

DOI:10.5588/ijtld.24.0267
PMID:39754278
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11924582/
Abstract
摘要